93 related articles for article (PubMed ID: 25695044)
1. New insights into malignant B-cell disorders.
Kyrtsonis MC; Shimizu K; Panayiotidis P; Pangalis GA
Biomed Res Int; 2015; 2015():128084. PubMed ID: 25695044
[No Abstract] [Full Text] [Related]
2. [Study of the effect of cytostatic therapy on the T- and B-cell population of peripheral blood in lymphocytic leukemia].
Tsveĭbakh AS; Gol'dman EI
Ter Arkh; 1978; 50(7):46-9. PubMed ID: 309667
[No Abstract] [Full Text] [Related]
3. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents.
Schwarz YX; Yang My; Qin D; Wu J; Jarvis WD; Grant S; Burton GF; Szakal AK; Tew JG
J Immunol; 1999 Dec; 163(12):6442-7. PubMed ID: 10586034
[TBL] [Abstract][Full Text] [Related]
4. Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.
Devine SM
Biol Blood Marrow Transplant; 2014 Jan; 20(1):14-9. PubMed ID: 24291621
[No Abstract] [Full Text] [Related]
5. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
6. Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis.
Pellier I; Renier G; Rakotonjanahary J; Audrain M; Berardi E; Gardembas M; Clavert A; Moles MP; Proust-Houdemont S; Reguerre Y; De Carli E; Georgin-Mege M; Garo E; Blanchard S; Miot C; Picard C; Delneste Y; Fischer A; Tanguy-Schmidt A; Jeannin P
J Allergy Clin Immunol; 2015 Mar; 135(3):818-20.e4. PubMed ID: 25420683
[No Abstract] [Full Text] [Related]
7. Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells.
Verhelle D; Corral LG; Wong K; Mueller JH; Moutouh-de Parseval L; Jensen-Pergakes K; Schafer PH; Chen R; Glezer E; Ferguson GD; Lopez-Girona A; Muller GW; Brady HA; Chan KW
Cancer Res; 2007 Jan; 67(2):746-55. PubMed ID: 17234786
[TBL] [Abstract][Full Text] [Related]
8. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
9. [B cell-directed therapy in rheumatoid arthritis. Multiple management concept?].
Musch A
Med Monatsschr Pharm; 2005 Dec; 28(12):422-5. PubMed ID: 16389869
[No Abstract] [Full Text] [Related]
10. Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma.
Campàs C; Santidrián AF; Domingo A; Gil J
Leukemia; 2005 Feb; 19(2):292-4. PubMed ID: 15549145
[No Abstract] [Full Text] [Related]
11. 2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation.
Voulgarelis M; Petroutsos G; Moutsopoulos HM; Skopouli FN
Arthritis Rheum; 2002 Aug; 46(8):2248-9. PubMed ID: 12209533
[No Abstract] [Full Text] [Related]
12. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
Beck ID; Lemmel EM
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
[No Abstract] [Full Text] [Related]
13. A stereoselective total synthesis of 7,8-O-isopropylidene iriomoteolide-3a.
Zhang Y; Deng L; Zhao G
Org Biomol Chem; 2011 Jun; 9(12):4518-26. PubMed ID: 21541369
[TBL] [Abstract][Full Text] [Related]
14. New chemotherapeutics strategies for the treatment of indolent lymphoid malignancies.
Cheson BD
Semin Hematol; 1999 Oct; 36(4 Suppl 5):26-33. PubMed ID: 10528913
[TBL] [Abstract][Full Text] [Related]
15. New developments in the field of diffuse large cell lymphoma.
Cabanillas F
Hematology; 2012 Apr; 17 Suppl 1():S98-100. PubMed ID: 22507792
[TBL] [Abstract][Full Text] [Related]
16. Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.
Ferraro AJ; Day CJ; Drayson MT; Savage CO
Nephrol Dial Transplant; 2005 Mar; 20(3):622-5. PubMed ID: 15735243
[No Abstract] [Full Text] [Related]
17. The evolving role of bendamustine in lymphoid malignancy: understanding the drug and its mechanism of action--introduction.
Leoni LM
Semin Hematol; 2011 Apr; 48 Suppl 1():S1-3. PubMed ID: 21530767
[No Abstract] [Full Text] [Related]
18. Complete response to alemtuzumab in a patient with B prolymphocytic leukemia.
Chaar BT; Petruska PJ
Am J Hematol; 2007 May; 82(5):417. PubMed ID: 17160995
[No Abstract] [Full Text] [Related]
19. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
[TBL] [Abstract][Full Text] [Related]
20. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
